The March issue of the
European Respiratory Review features an article that discusses the future of monoclonal antibodies in the treatment of asthma, as well as other new ways of managing the condition. Future views based on the paradigm shifts that are soon to occur are also discussed. To read this open access paper and much more, visit
err.ersjournals.com
No comments:
Post a Comment